[Bevacizumab or ranibizumab, or the tale of Robin Hood and King Richard Lion Heart].
نویسنده
چکیده
منابع مشابه
Online Distribution and Load Balancing Optimization Using the Robin Hood and Johnson Hybrid Algorithm
Proper planning of assembly lines is one of the production managers’ concerns at the tactical level so that it would be possible to use the machine capacity, reduce operating costs and deliver customer orders on time. The lack of an efficient method in balancing assembly line can create threatening problems for manufacturing organizations. The use of assembly line balancing methods cannot balan...
متن کاملAdverse events with intravitreal injection of vascular endothelial growth factor inhibitors: nested case-control study
OBJECTIVE To assess the risk of systemic adverse events associated with intravitreal injections of vascular endothelial growth factor inhibiting drugs. DESIGN Population based nested case-control study. SETTING Ontario, Canada. PARTICIPANTS 91,378 older adults with a history of physician diagnosed retinal disease identified between 1 April 2006 and 31 March 2011. Cases were 1477 patients ...
متن کاملAlternative treatments to inhibit VEGF in age-related choroidal neovascularisation: 2-year findings of the IVAN randomised controlled trial
BACKGROUND Bevacizumab has been suggested to have similar effectiveness to ranibizumab for treatment of neovascular age-related macular degeneration. The Inhibition of VEGF in Age-related choroidal Neovascularisation (IVAN) trial was designed to compare these drugs and different regimens. Here, we report the findings at the prespecified 2-year timepoint. METHODS In a multicentre, 2×2 factoria...
متن کاملConversion back to bevacizumab or ranibizumab for recurrent neovascular activity with aflibercept in age-related macular degeneration: a case series
BACKGROUND Neovascular age-related macular degeneration often requires chronic therapy with anti-VEGF agents, and patients with recurrent disease are challenging to manage. METHODS This retrospective case series evaluates patients who were switched from bevacizumab or ranibizumab to aflibercept and then back again because of recurrent fluid on optical coherence tomography (OCT) by reporting c...
متن کاملFeasibility and efficacy of a mass switch from ranibizumab (Lucentis) to bevacizumab (Avastin) for treatment of neovascular age-related macular degeneration.
PURPOSE To assess the feasibility and potential obstacles of a departmental switch from ranibizumab (Lucentis, Genentech, South San Francisco, CA) to bevacizumab (Avastin, Genentech) for the treatment of neovascular age-related macular degeneration (AMD). METHODS A total of 154 eyes treated for wet AMD with ranibizumab or bevacizumab were examined over a 10-month period. The treatment protoco...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Archivos de la Sociedad Espanola de Oftalmologia
دوره 82 9 شماره
صفحات -
تاریخ انتشار 2007